Lagrangian description of the atmospheric flow from Eulerian tracer advection with relaxation

The Lagrangian representation of fluid flows offers a natural perspective to study many kinds of physical mechanisms. By contrast, the Eulerian representation is more convenient from a diagnostic point of view. This article attempts to combine elements of both worlds by proposing an Eulerian method that allows one to extract Lagrangian information about the atmospheric flow. The method is based on the offline advection of passive tracer fields and includes a relaxation term. The latter device allows one to run the integration in a continuous fashion without the need for reinitialization. As a result one obtains accumulated Lagrangian information, for example, about the recent parcel displacement or the recent parcel-based diabatic heating, at each point of an Eulerian grid at any time step. The method is implemented with a pseudospectral algorithm suitable for gridded global atmospheric data and compared with the more traditional trajectory method. The method's utility is demonstrated on the basis of a few examples, which relate to cloud formation and the development of temperature anomalies. The examples highlight that the method provides a convenient diagnostic of parcel-based changes, paving an intuitive way to explore the physical processes involved. Due to its gridpoint-based nature, the proposed method can be applied to large data sets in a straightforward and computationally efficient manner, suggesting that the method is particularly useful for climatological analyses

The Absence of Athletic Avatars' Effects on Physiological and Perceptual Responses while Cycling in Virtual Reality

Virtual reality (VR) allows to embody avatars—the digital self-representation of the user. An avatar’s appearance can change users’ perception and behavior—a phenomenon known as the Proteus effect. Previous work found that athletic avatars can reduce heart rate and perceived exertion during physical effort. Although these findings are promising to create more effective VR exercises, they have not been replicated yet. Hence, the reliability and consistency of such effects is unknown. Therefore, we conducted a study with 32 participants to investigate physiological and perceptual effects of athletic avatars while cycling in VR following a standardized exercise protocol. We could not find effects of the avatars’ athletic appearance on heart rate, perceived exertion, and imagined velocity. Our findings indicate that athletic avatars do not necessarily affect users during physical exertion. We discuss potential factors that can cause the Proteus effect fail to occur

Satellite Observations for Detecting and Forecasting Sea-Ice Conditions: A Summary of Advances Made in the SPICES Project by the EU’s Horizon 2020 Programme

The detection, monitoring, and forecasting of sea-ice conditions, including their extremes, is very important for ship navigation and offshore activities, and for monitoring of sea-ice processes and trends. We summarize here recent advances in the monitoring of sea-ice conditions and their extremes from satellite data as well as the development of sea-ice seasonal forecasting capabilities. Our results are the outcome of the three-year (2015–2018) SPICES (Space-borne Observations for Detecting and Forecasting Sea-Ice Cover Extremes) project funded by the EU’s Horizon 2020 programme. New SPICES sea-ice products include pancake ice thickness and degree of ice ridging based on synthetic aperture radar imagery, Arctic sea-ice volume and export derived from multisensor satellite data, and melt pond fraction and sea-ice concentration using Soil Moisture and Ocean Salinity (SMOS) radiometer data. Forecasts of July sea-ice conditions from initial conditions in May showed substantial improvement in some Arctic regions after adding sea-ice thickness (SIT) data to the model initialization. The SIT initialization also improved seasonal forecasts for years with extremely low summer sea-ice extent. New SPICES sea-ice products have a demonstrable level of maturity, and with a reasonable amount of further work they can be integrated into various operational sea-ice services.</jats:p

Association of candidate pharmacogenetic markers with platinum-induced ototoxicity:PanCareLIFE dataset

Genetic association studies suggest a genetic predisposi- tion for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase ( TPMT ) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a pharmacogenetic guideline. The PanCareLIFE cross- sectional cohort study evaluated the genetic associations in a large pan-European population and assessed the diagnos- tic accuracy of the genetic markers. 1,112 pediatric cancer survivors who had provided biomaterial for genotyping were screened for participation in the pharmacogenetic association study. 900 participants qualified for inclusion. Based on the assessment of original audiograms, patients were assigned to three phenotype categories: no, minor, and clinically relevant hearing loss. Fourteen variants in eleven candidate genes ( ABCC3, OTOS, TPMT, SLC22A2, NFE2L2, SLC16A5, LRP2, GSTP1, SOD2, WFS1, and ACYP2 ) were genotyped. The genotype and phenotype data represent a resource for conducting meta- analyses to derive a more precise pooled estimate of the ef- fects of genes on the risk of hearing loss due to platinum treatment

Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset

Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a pharmacogenetic guideline. The PanCareLIFE cross-sectional cohort study evaluated the genetic associations in a large pan-European population and assessed the diagnostic accuracy of the genetic markers. 1,112 pediatric cancer survivors who had provided biomaterial for genotyping were screened for participation in the pharmacogenetic association study. 900 participants qualified for inclusion. Based on the assessment of original audiograms, patients were assigned to three phenotype categories: no, minor, and clinically relevant hearing loss. Fourteen variants in eleven candidate genes (ABCC3, OTOS, TPMT, SLC22A2, NFE2L2, SLC16A5, LRP2, GSTP1, SOD2, WFS1, and ACYP2) were genotyped. The genotype and phenotype data represent a resource for conducting meta-analyses to derive a more precise pooled estimate of the effects of genes on the risk of hearing loss due to platinum treatment

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Lagrangian description of the atmospheric flow from Eulerian tracer advection with relaxation

AbstractThe Lagrangian representation of fluid flows offers a natural perspective to study many kinds of physical mechanisms. By contrast, the Eulerian representation is more convenient from a diagnostic point of view. This article attempts to combine elements of both worlds by proposing an Eulerian method that allows one to extract Lagrangian information about the atmospheric flow. The method is based on the offline advection of passive tracer fields and includes a relaxation term. The latter device allows one to run the integration in a continuous fashion without the need for reinitialization. As a result one obtains accumulated Lagrangian information, for example, about the recent parcel displacement or the recent parcel‐based diabatic heating, at each point of an Eulerian grid at any time step. The method is implemented with a pseudospectral algorithm suitable for gridded global atmospheric data and compared with the more traditional trajectory method. The method's utility is demonstrated on the basis of a few examples, which relate to cloud formation and the development of temperature anomalies. The examples highlight that the method provides a convenient diagnostic of parcel‐based changes, paving an intuitive way to explore the physical processes involved. Due to its gridpoint‐based nature, the proposed method can be applied to large data sets in a straightforward and computationally efficient manner, suggesting that the method is particularly useful for climatological analyses.The Lagrangian representation of fluid flows offers the most natural perspective to study many kinds of physical mechanisms; by contrast, the Eulerian representation is more convenient from a diagnostic point of view. This article attempts to combine elements of both worlds by proposing an Eulerian method that allows one to extract Lagrangian information about the atmospheric flow. The method enables one to easily produce a sequence of maps showing accumulated Lagrangian changes. Deutsche Forschungsgemeinschaft http://dx.doi.org/10.13039/50110000165